News related to Amphetamine and/or conditions it is approved for
$17 Million To UC San Diego For Methamphetamine/AIDS Research
Source: HIV / AIDS News From Medical News Today [2009.11.15]
Igor Grant, MD, professor of psychiatry at the University of California, San Diego School of Medicine, and colleagues have been awarded a $17 million grant from the National Institute on Drug Abuse to establish the Translational Methamphetamine AIDS Research Center (TMARC) at UC San Diego. Grant is director of the HIV Neurobehavioral Research Center (HNRC), a clinical research center designated and funded by the National Institute of Mental Health.
Adult Working Memory May Be Impaired By Amphetamine Use In Adolescence
Source: ADHD News From Medical News Today [2009.10.22]
Rats exposed to high doses of amphetamines at an age that corresponds to the later years of human adolescence display significant memory deficits as adults - long after the exposure ends, researchers report. The declines in short-term or "working" memory are most pronounced when the rats are exposed during adolescence, rather than as adults, the researchers found.
KemPharm, Inc. Announces Initiation Of Phase 1 Trial Of KP106 For ADHD
Source: ADHD News From Medical News Today [2009.10.25]
KemPharm, Inc. announced that it has commenced a Phase 1 clinical trial in healthy volunteers of its novel prodrug compound, KP106, which is in development for the treatment of attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of d-amphetamine and a ligand, is the lead investigational candidate from KemPharm's proprietary ligand activated therapy (LAT) platform, which creates improved versions of FDA-approved drugs.
|
